REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW 12,330
+410 (3.44%)
At close: Jul 17, 2025, 3:30 PM KST
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 225.96 billion as of July 18, 2025. Its market cap has decreased by -8.13% in one year.
Market Cap
225.96B
Enterprise Value
422.83B
Revenue
148.04B
Ranking
n/a
PE Ratio
55.99
Stock Price
12,330.00
Market Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 225.96B, an increase of 37.32%. That is a compound annual growth rate of 2.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 39.45T |
| ALTEOGEN | 25.06T |
| Yuhan | 8,429.07B |
| SK Biopharmaceuticals | 7,635.54B |
| HLB Co., Ltd. | 6,834.05B |
| PharmaResearch | 6,150.67B |
| Peptron | 5,521.47B |